Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
Department of Biochemistry, University of Toronto, Toronto, Canada.
Elife. 2022 Jan 13;11:e72908. doi: 10.7554/eLife.72908.
Malaria is a global health burden, with (Pf) and (Pv) responsible for the majority of infections worldwide. Circumsporozoite protein (CSP) is the most abundant protein on the surface of sporozoites, and antibodies targeting the central repeat region of CSP can prevent parasite infection. Although much has been uncovered about the molecular basis of antibody recognition of the PfCSP repeats, data remains scarce for PvCSP. Here, we performed molecular dynamics simulations for peptides comprising the PvCSP repeats from strains VK210 and VK247 to reveal how the PvCSP central repeats are highly disordered, with minor propensities to adopt turn conformations. Next, we solved eight crystal structures to unveil the interactions of two inhibitory monoclonal antibodies (mAbs), 2F2 and 2E10.E9, with PvCSP repeats. Both antibodies can accommodate subtle sequence variances in the repeat motifs and recognize largely coiled peptide conformations that also contain isolated turns. Our structural studies uncover various degrees of Fab-Fab homotypic interactions upon recognition of the PvCSP central repeats by these two inhibitory mAbs, similar to potent mAbs against PfCSP. These findings augment our understanding of host interactions and contribute molecular details of Pv inhibition by mAbs to unlock structure-based engineering of PvCSP-based vaccines.
疟疾是全球健康负担,(Pf)和(Pv)负责全球大多数感染。环子孢子蛋白(CSP)是孢子表面最丰富的蛋白质,针对 CSP 中心重复区的抗体可以预防寄生虫感染。尽管已经发现了很多关于抗体识别 PfCSP 重复的分子基础的信息,但关于 PvCSP 的数据仍然很少。在这里,我们对来自菌株 VK210 和 VK247 的 PvCSP 重复肽进行了分子动力学模拟,以揭示 PvCSP 中心重复序列是如何高度无序的,只有很小的倾向采用转弯构象。接下来,我们解决了八个晶体结构,揭示了两种抑制性单克隆抗体(mAbs)2F2 和 2E10.E9 与 PvCSP 重复序列的相互作用。这两种抗体都可以适应重复基序中的细微序列变异,并识别出主要呈卷曲构象的肽,其中还包含孤立的转弯。我们的结构研究揭示了这两种抑制性 mAbs 识别 PvCSP 中心重复序列时 Fab-Fab 同型相互作用的不同程度,类似于针对 PfCSP 的有效 mAbs。这些发现增加了我们对宿主相互作用的理解,并为基于 mAbs 的 Pv 抑制提供了分子细节,以解锁基于 PvCSP 的疫苗的基于结构的工程。